GlassScriptPhysician profile
Krishnan Rajagopal
NPI 1710922190
$455.19
in general payments reported to CMS, 2019-2025
20 companies · $41.50 in 2025
The $41.50 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.90 · 2021: $5.00 · 2022: $18.15 · 2023: $165 · 2024: $210 · 2025: $41.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $417.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $44.67 | 2024 | Rexulti |
| Glaxosmithkline, LLC. | $33.82 | 2023-2024 | Nucala, Shingrix, Arexvy |
| Lilly USA, LLC | $31.29 | 2024 | Mounjaro, Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $31.11 | 2024 | Trintellix |
| Boston Scientific Corporation | $29.35 | 2024 | Watchman Flx |
| Pfizer INC. | $27.07 | 2023 | |
| Amgen INC. | $26.69 | 2023-2024 | Evenity, Prolia |
| Abiomed | $24.24 | 2025 | |
| Resmed Corp | $23.39 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $22.31 | 2024 | Crysvita |
| Axsome Therapeutics, INC. | $21.90 | 2024 | Auvelity |
| Shield Therapeutics INC | $19.89 | 2023 | Accrufer |
| Janssen Pharmaceuticals, INC | $19.19 | 2023 | Spravato |
| Grifols USA, LLC | $18.15 | 2022 | |
| Insmed, INC. | $17.26 | 2025 | Arikayce |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.45 | 2023 | Xifaxan, Trulance |
| Abbvie INC. | $15.07 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.90 | 2019 | |
| Electromed, INC. | $14.44 | 2023 | Smartvest |
| United Therapeutics Corporation | $5.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishnan Rajagopal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.